I am in the breast imaging business to help to find small breast cancers, but the little ones are tough to identify sometimes.
Yesterday was a busy day in the mammography screening world. One technologist commented, “It looks like the beginning of the July to January mammo push.” I don’t know whether to be excited at the possibility of finding occult breast cancers for more women, or to be a bit scared of the increased opportunities for missing a small breast cancer.
I am in the breast imaging business to help to find small breast cancers. Statistics indicate that treatment of breast cancers smaller than 1 cm gives the woman a 99 percent chance of living a life as if she had never had breast cancer.
So sometimes I wonder what is the point of debating whether a cancer will kill a woman or not. It’s kind of a conundrum. If the parameters used to decide if a cancer is a killing cancer are 100 percent reliable and 100 percent accurate in prediction, then analyzing a cancer for its effect on mortality would be useful. However, the evaluation of cancers for killing potential is not a useable technology at the present time. So, I rely on trying to find cancers smaller than 1 cm to help women to live normal lives in spite of their breast cancer.
The little ones are tough to identify sometimes. They do not have typical appearances. They easily hide amongst the fibroglandular densities, protruding slightly from the contour of the tissue or appearing in a small previously fatty area. Sometimes time tells the story when a small nondescript nodule declares itself with speculated margins and increased density. Using the 20/20 retrospectoscope is disconcerting because the small nondescript density usually can be seen, benignly sitting amongst other similar breast densities.
Radiologists do miss lesions on screening mammograms. Leonard Berlin, MD, in his book “Malpractice Issues in Radiology” quotes studies indicating of miss rates of 25 percent. The itty-bittys just don’t stand out in the crowd.
I’ll just keep trying to find the little ones anyway. Happy beginning of screening mammography season!
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.